We are live on
!
Find out more
DCM
Driehaus Capital Management Portfolio holdings
AUM
$13.6B
1-Year Est. Return
173.98%
This Fund
S&P 500
This Quarter
Est. Return
-10.34%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.17B
AUM Growth
-$1.97B
(-24%)
Cap. Flow
-$820M
Cap. Flow
% of AUM
-13.27%
Top 10 Holdings %
Top 10 Hldgs %
17.81%
Holding
470
New
92
Increased
125
Reduced
120
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTI Consulting
FCN
|
+$54.3M |
| 2 |
Xenon Pharmaceuticals
XENE
|
+$33M |
| 3 |
Flywire
FLYW
|
+$32.6M |
| 4 |
America Movil
AMX
|
+$31M |
| 5 |
FIVE9
FIVN
|
+$29.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$85.8M |
| 2 |
United Parks & Resorts
PRKS
|
+$64.2M |
| 3 |
Vale
VALE
|
+$56.2M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$46M |
| 5 |
Axcelis
ACLS
|
+$45.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.12% |
| 2 | Technology | 17.89% |
| 3 | Industrials | 14.18% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
nCino
NCNO
$2.03B
| $9.55M | 0.15% |
+308,807
| New | +$10.9M |
|
202
Neurocrine Biosciences
NBIX
$18.4B
| $9.54M | 0.15% |
+97,884
| New | +$9.03M |
|
203
Tractor Supply
TSCO
$16.5B
| $9.53M | 0.15% |
245,895
+5,240
| +2% | +$213K |
|
204
Bio-Techne
TECH
$11.2B
| $9.5M | 0.15% |
109,632
+2,772
| +3% | +$260K |
|
205
Live Nation Entertainment
LYV
$42.1B
| $9.44M | 0.15% |
114,290
+3,566
| +3% | +$343K |
|
|
AXON
206
Axon Enterprise
AXON
$44.1B
| $9.41M | 0.15% |
100,988
+2,857
| +3% | +$302K |
|
|
CINC
207
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $9.18M | 0.15% |
+487,279
| New | +$9.33M |
|
208
Uranium Energy
UEC
$4.67B
| $9.14M | 0.15% |
+2,967,540
| New | +$12.3M |
|
209
AtriCure
ATRC
$2.01B
| $9.06M | 0.15% |
221,643
+13,414
| +6% | +$635K |
|
210
Alphatec Holdings
ATEC
$1.43B
| $9M | 0.15% |
1,375,501
+238,480
| +21% | +$2.2M |
|
|
DAWN
211
DELISTED
Day One Biopharmaceuticals
DAWN
| $8.98M | 0.15% |
501,689
+98,231
| +24% | +$1.01M |
|
|
PETQ
212
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $8.91M | 0.14% |
530,852
-81,651
| -13% | -$1.5M |
|
|
SEE
213
DELISTED
Sealed Air
SEE
| $8.76M | 0.14% |
151,772
-112,735
| -43% | -$7.12M |
|
214
Hyatt Hotels
H
$17.8B
| $8.73M | 0.14% |
118,176
-72,168
| -38% | -$6.26M |
|
|
ECOM
215
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $8.66M | 0.14% |
594,049
-827,483
| -58% | -$11.8M |
|
|
KDNY
216
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.61M | 0.14% |
+492,303
| New | +$7.73M |
|
217
Applied Industrial Technologies
AIT
$12.9B
| $8.37M | 0.14% |
+86,985
| New | +$8.78M |
|
218
Alnylam Pharmaceuticals
ALNY
$38.5B
| $8.21M | 0.13% |
56,270
+1,821
| +3% | +$258K |
|
219
Aviat Networks
AVNW
$264M
| $8.2M | 0.13% |
327,585
-2,112
| -0.6% | -$61.1K |
|
220
Autohome
ATHM
$2.65B
| $8.05M | 0.13% |
204,810
-153,988
| -43% | -$4.79M |
|
221
CF Industries
CF
$18.9B
| $8.02M | 0.13% |
93,524
-157,729
| -63% | -$15.3M |
|
|
PHLT
222
DELISTED
Performant Healthcare Inc
PHLT
| $8.01M | 0.13% |
3,047,313
+158,832
| +5% | +$394K |
|
223
Vita Coco
COCO
$3.97B
| $7.94M | 0.13% |
810,958
-202,957
| -20% | -$2.15M |
|
224
Zscaler
ZS
$24.5B
| $7.94M | 0.13% |
53,097
-76,098
| -59% | -$13.5M |
|
|
LOKM
225
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
| $7.86M | 0.13% |
801,517
| – | – |
|
Similar funds
CC
PMAM
SA
PSCM
WHG
AA
WA
SAM
Driehaus Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Driehaus Capital Management held 470 positions worth $6.17B, down 24% from $8.14B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Driehaus Capital Management withdrew a net $820M in Q2 2022, closing 118 positions and reducing 120 holdings. Its most notable exit was Infosys, an estimated $85.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Driehaus Capital Management opened a new position in FTI Consulting worth $59.5M.
- Driehaus Capital Management's largest Q2 2022 buy was FTI Consulting: 329,108 shares worth $59.5M.
- Driehaus Capital Management added most to Xenon Pharmaceuticals in Q2 2022, an estimated $33M increase.
- Driehaus Capital Management's biggest Q2 2022 reduction was Axcelis, cutting an estimated $45.1M.
- Driehaus Capital Management fully exited Infosys in Q2 2022, selling an estimated $85.8M.
- Driehaus Capital Management's ten largest holdings make up 18% of its $6.17B portfolio in Q2 2022.
- Driehaus Capital Management opened 92 new positions and closed 118 in Q2 2022.
- Driehaus Capital Management's portfolio value fell 24% quarter-over-quarter to $6.17B.
Based on Driehaus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.